about
Novel genetic variants in miR-191 gene and familial ovarian cancerRegulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunityTumor infiltrating lymphocytes: indicators of tumor-related immune responsesDNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancerEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerImmunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskSafety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationExperimental and computational studies indicate specific binding of pVHL protein to Aurora-A kinaseGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesOvarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part onePALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSCommon variants at 19p13 are associated with susceptibility to ovarian cancer.No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumRobust detection of immune transcripts in FFPE samples using targeted RNA sequencing.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancersHarmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumDirect tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.Tumor associated antigen recognition by autologous serum in patients with breast cancer.Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells.Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapyHormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyTowards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational researchAntigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Frequent MAGE mutations in human melanomaIntertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancerSeromic profiling of ovarian and pancreatic cancer.Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.
P50
Q21093320-8457B6D7-A350-435A-81C1-6AE72ED2788CQ24610550-9120E317-715F-4074-8023-54A797261C15Q24615071-53C17801-98EF-4B30-9FA1-B3C064AD2B30Q24615113-A5F23055-151C-407F-9656-4AEAB2351F56Q24633316-E9F08C61-CE3F-4F02-9050-CD1ED1239241Q26765115-DA1E4223-1849-4202-B446-77EBFBA58433Q26799669-2844B46F-2EB5-487D-830D-D7A2D0BD7FD9Q27860857-CEAF150D-FB04-401C-808E-87D5E59AF754Q28266112-EA04D925-2B1C-49ED-BEB9-2C1905D8974CQ28269232-87DD8F4B-B45F-48F4-8EE3-E8BF17E2146EQ28388497-194D1C9F-D11D-495D-A5C0-EEB5FF010F18Q28538384-C062EA1A-076C-4D98-9E06-966C50525519Q28553703-AA4C5AF6-6AC4-496D-BCE9-82D542150874Q28584533-3A77953A-1E0C-4126-BA9D-EFB7C40A3611Q29417145-593AE531-E498-4E6A-ADB3-960918CF3C4EQ30275832-29EE2702-5DEC-4B51-AF6F-8821FD2C470FQ30276610-DA754B60-1ED5-453C-8F6E-8FD24B7E5A29Q30358368-FD3D1AA6-7186-4380-B965-365717DB4B28Q30374367-88433B18-AB4E-4B25-8271-303A97314385Q30377229-418EFCB6-80D0-4637-B8A2-7F38D4DA7FA1Q30439109-8710FC85-1A54-4A5C-804A-9F4C4A8BE2ECQ30667174-18DD1394-90E5-4567-8D34-AD4B6757FE53Q31123493-0FACCA06-4214-471B-AF63-6E7322190466Q33196744-81D925D8-E082-4141-A932-489C0C4211A4Q33203841-435A2266-03EA-4DFB-ABEE-0AE39704F8E0Q33209639-60D9B376-655A-4CC9-94B4-2EFCC336520FQ33301098-ACFF09F6-583F-466E-B5DD-25C4DB2782FEQ33470293-9E778608-5F08-4E84-B1CD-B324E5F8EE28Q33533008-3679C06D-5EC9-479B-8BFD-BCB4A97FA8A5Q33551425-A00616CA-3D3D-4B67-B97C-D419EA678BA3Q33576391-C558926A-E80E-47C4-86F2-BBC20E6A3ACEQ33615227-5EA8ED3F-2918-49ED-99A3-FD474D753421Q33681985-596739E8-84F8-4A65-80A4-5BA3479AFF87Q33700477-7E6F9AE5-D878-4744-BFC7-341C2ABE193AQ33715446-7689F419-7817-42FD-80A6-E0305100AA94Q33739967-D8740208-5A11-4579-B92E-6DA39E329970Q33771027-59435A48-6C47-4E01-A017-A0B69664588BQ33778612-A2EBD2A2-0FF7-46E8-AC9D-B48FF9DF71D1Q33842859-87384224-B03B-41BD-910D-7496804A798AQ33915813-1C7D70D4-9ECE-41BE-8109-31822D620212
P50
description
onderzoeker
@nl
name
Kunle Odunsi
@ast
Kunle Odunsi
@en
Kunle Odunsi
@es
Kunle Odunsi
@sl
type
label
Kunle Odunsi
@ast
Kunle Odunsi
@en
Kunle Odunsi
@es
Kunle Odunsi
@sl
prefLabel
Kunle Odunsi
@ast
Kunle Odunsi
@en
Kunle Odunsi
@es
Kunle Odunsi
@sl